Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response.
Dec 1, 2021
Beyond COVID-19: How mRNA technology could transform how we treat disease
Dr. Anna Blakney, assistant professor at UBC’s Michael Smith Laboratories and school of biomedical engineering, describes how mRNA technology could transform how we treat disease.
Aug 4, 2021
UBC experts on Pfizer COVID-19 vaccine approval for adolescents
UBC experts are available to comment on Health Canada’s approval of the Pfizer-BioNTech vaccine for adolescents aged 12 and up.
May 5, 2021
COVID-19 vaccinations: what you need to know about the second dose
In Canada, currently approved COVID-19 vaccines—from Moderna and Pfizer-BioNTech—have demonstrated remarkable efficacy based on two doses taken at specified intervals. But what happens if you contract COVID-19 in between shots?
Feb 12, 2021